Fast Five Quiz: Obstructive Sleep Apnea Key Aspects

Zab Mosenifar, MD

Disclosures

November 21, 2019

All interventions to improve tolerance of continuous positive airway pressure (CPAP) should be attempted prior to deciding that treatment has failed. CPAP is considered the gold standard of therapy for OSA and can usually reverse this condition quickly with the appropriate titration of devices.

Pharmacologic therapy is not part of primary treatment. No clinically useful drug therapy is currently available, except in certain cases of excessive sleepiness remaining after apparently successful treatment. In such cases, modafinil can be used at doses of 200-400 mg/d. (Armodafinil, the R-enantiomer of modafinil, has also been FDA approved for use in these patients.) In addition, solriamfetol, a dopamine/norepinephrine reuptake inhibitor (DNRI), received FDA approval in 2019 to improve wakefulness in patients with excessive daytime sleepiness who have OSA.

Patients in whom noninvasive medical therapy (eg, CPAP, OAs) fails should be offered surgical options. Patients should be made aware of the success rates for each surgical procedure. They should be informed that they might require more than one surgical procedure, some fairly extensive, to cure OSA. Refer patients only to centers that have personnel experienced in these special surgical techniques.

For more on the treatment of OSA, read here.

Editor's Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....